DGAP-Adhoc: NEXUS AG: Strong increase in Result and Sales in the first Quarter 2013

NEXUS AG / Key word(s): Quarter Results

10.05.2013 08:20

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Villingen-Schwenningen, 10 May 2013 NEXUS AG, specialized in medical
software, was able to increase sales by 20% from KEUR 13,855 in Q1-2012 to
KEUR 16,604 in Q1-2013. The operating result after taxes increased by 20.5%
to KEUR 1,702 (Q1-2012: KEUR 1,413).

The sales increase in the Healthcare Software Division was 12.9% and
amounted to KEUR 14,509 following KEUR 12,853 in the previous year. Sales
in the Healthcare Service Division increased by approx. 109.1% in the first
quarter 2013 to KEUR 2,095 (Q1-2012: KEUR 1,002). The sales of ASS.TEC GmbH
and E&L medical systems GmbH consolidated for the first time contributed to
part of the sale increase (12.9%).

The result before taxes improved by 18.1% to KEUR 1,662 (Q1-2012: KEUR
1,407) in comparison to the previous year, and the result after taxes
increased to KEUR 1,702 following KEUR 1,413 in the previous year (+20.5%).
The EBITDA increased by approx. 17.1% to KEUR 3,240 (Q1-2012: KEUR 2,767)
during the reporting period.

The cash flow from on-going business transactions was at a high level at
KEUR 4,547, but was lower than in the previous year (Q1-2012: KEUR 6,353).
The share of international business in sales volume was 42.9% or KEUR 7,125
in the first quarter (Q1-2012: KEUR 6,952).

With approx. EUR 69.7 million equity capital, NEXUS AG has a healthy
balance sheet and sufficient capital to finance further growth. Cash
reserves increased by approx. KEUR 2,941 to EUR 25.9 million compared to
the end of the business year (31 December 2012: EUR 23.1 million).

NEXUS - the eHealth specialist - develops and sells modular software
solutions internationally for healthcare systems in the areas of Clinical
Information Systems? (CIS), ?Diagnostic Information Systems? (DIS) and ?IT
Services?. Comprehensive solutions for hospitals and psychiatric
institutions are designed and supported within NEXUS / CIS. The solutions
of NEXUS / DIS cover special ward and specialist areas for radiology,
pathology as well as for
gynecology / obstetrics and intensive care medicine. NEXUS bets on modern,
modular software architecture in all product areas, which enables flexible
and step-by-step introduction of NEXUS systems. More than 578 staff members
in the NEXUS Group develop software solutions for the healthcare sector,
with which approximately 158,600 users in 23 countries work.

---------------------------------------------------------------------------

Information and Explaination of the Issuer to this News:

Further Information:

NEXUS AG
Mr. Simon Holzer

Tel.: +49 (0) 77 21/84 82 0
Fax: +49 (0) 77 21/84 82 311
ir@nexus-ag.de
www.nexus-ag.de

---------------------------------------------------------------------------

Language: English
Company: NEXUS AG
Auf der Steig 6
78052 Villingen-Schwenningen
Germany
Phone: +49 (0)7721 8482-0
Fax: +49 (0)7721 8482-888
E-mail: mail@nexus-ag.de
Internet: www.nexus-ag.de
ISIN: DE0005220909
WKN: 522090
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, Düsseldorf, München, Stuttgart

End of Announcement DGAP News-Service

---------------------------------------------------------------------------